Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease

Clinical Immunology

Volumn 127, Issue 1, 2008, Pages 49-55

  Seiderer, Julia ^a   Dambacher, Julia ^a   Leistner, Dorothea ^a   Tillack, Cornelia ^a   Glas, Jürgen ^a   Niess, Jan Hendrik ^b,c   Pfennig, Simone ^a   Jürgens, Matthias ^a   Müller Myhsok, Bertram ^d   Göke, Burkhard ^a   Ochsenkühn, Thomas ^a   Lohse, Peter ^a   Reinecker, Hans Christian ^c   Brand, Stephan ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c Center for Inflammatory Bowel Disease   (United States)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

CARD15; Chemokine; Crohn's disease; CXCL16; CXCR6; Genetics; Inflammatory bowel disease; Intestinal inflammation; Polymorphism; Ulcerative colitis

Indexed keywords

ALANINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CXCL16 CHEMOKINE; GENOMIC DNA; VALINE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; COLON; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROHN DISEASE; DISEASE PREDISPOSITION; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE PHENOTYPE CORRELATION; HUMAN; ILEUM; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RISK; STENOSIS; ULCERATIVE COLITIS;

ADULT; AGE OF ONSET; CHEMOKINES, CXC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, SCAVENGER;

EID: 40849100426     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2007.11.016     Document Type: Article

References (38)

1. Xavier R.J., and Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448 (2007) 427-434
2. Sartor R.B. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3 (2006) 390-407
3. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., Cortot A., Modigliani R., Laurent-Puig P., Gower-Rousseau C., Macry J., Colombel J.F., Sahbatou M., and Thomas G. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
4. Ogura Y.B.D., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., Bayless T.M., Kirschner B.S., Hanauer S.B., Nunez G., and Cho J.H. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
5. Brand S., Staudinger T., Schnitzler F., Pfennig S., Hofbauer K., Dambacher J., Seiderer J., Tillack C., Konrad A., Crispin A., Goke B., Lohse P., and Ochsenkuhn T. The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease. Inflamm. Bowel Dis. 11 (2005) 645-652
6. Brand S., Hofbauer K., Dambacher J., Schnitzler F., Staudinger T., Pfennig S., Seiderer J., Tillack C., Konrad A., Goke B., Ochsenkuhn T., and Lohse P. Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype. Am. J. Gastroenterol. 101 (2006) 99-106
7. Thalmaier D., Dambacher J., Seiderer J., Konrad A., Schachinger V., Pfennig S., Otte J.M., Crispin A., Goke B., Ochsenkuhn T., Lohse P., and Brand S. The +1059G/C polymorphism in the C-reactive protein (CRP) gene is associated with involvement of the terminal ileum and decreased serum CRP levels in patients with Crohn's disease. Aliment. Pharmacol. Ther. 24 (2006) 1105-1115
8. Dambacher J., Staudinger T., Seiderer J., Sisic Z., Schnitzler F., Pfennig S., Hofbauer K., Konrad A., Tillack C., Otte J.M., Diebold J., Göke B., Ochsenkühn T., Lohse P., and Brand S. Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease. Inflamm. Bowel Dis. 13 (2007) 71-82
9. Dwinell M.B., Eckmann L., Leopard J.D., Varki N.M., and Kagnoff M.F. Chemokine receptor expression by human intestinal epithelial cells. Gastroenterology 117 (1999) 359-367
10. Jordan N.J., Kolios G., Abbot S.E., Sinai M.A., Thompson D.A., Petraki K., and Westwick J. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J. Clin. Invest. 104 (1999) 1061-1069
11. Brand S., Sakaguchi T., Gu X., Colgan S.P., and Reinecker H.C. Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells. Gastroenterology 122 (2002) 166-177
12. Brand S., Dambacher J., Beigel F., Olszak T., Diebold J., Otte J.M., Goke B., and Eichhorst S.T. CXCR4 and CXCL12 are inversely expressed in colorectal cancer cells and modulate cancer cell migration, invasion and MMP-9 activation. Exp. Cell Res. 310 (2005) 117-130
13. Brand S., Olszak T., Beigel F., Diebold J., Otte J.M., Eichhorst S.T., Goke B., and Dambacher J. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J. Cell. Biochem. 97 (2006) 709-723
14. Wilbanks A., Zondlo S.C., Murphy K., Mak S., Soler D., Langdon P., Andrew D.P., Wu L., and Briskin M. Expression cloning of the STRL33/BONZO/TYMSTR ligand reveals elements of CC, CXC, and CX3C chemokines. J. Immunol. 166 (2001) 5145-5154
15. Shimaoka T., Nakayama T., Kume N., Takahashi S., Yamaguchi J., Minami M., Hayashida K., Kita T., Ohsumi J., Yoshie O., and Yonehara S. Cutting edge: SR-PSOX/CXC chemokine ligand 16 mediates bacterial phagocytosis by APCs through its chemokine domain. J. Immunol. 171 (2003) 1647-1651
16. Matloubian M., David A., Engel S., Ryan J.E., and Cyster J.G. A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat. Immunol. 1 (2000) 298-304
17. Deng H.K., Unutmaz D., KewalRamani V.N., and Littman D.R. Expression cloning of new receptors used by simian and human immunodeficiency viruses. Nature 388 (1997) 296-300
18. Liao F., Alkhatib G., Peden K.W., Sharma G., Berger E.A., and Farber J.M. STRL33, a novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1. J. Exp. Med. 185 (1997) 2015-2023
19. Loetscher M., Amara A., Oberlin E., Brass N., Legler D., Loetscher P., D'Apuzzo M., Meese E., Rousset D., Virelizier J.L., Baggiolini M., Arenzana-Seisdedos F., and Moser B. TYMSTR, a putative chemokine receptor selectively expressed in activated T cells, exhibits HIV-1 coreceptor function. Curr. Biol. 7 (1997) 652-660
20. Kim C.H., Kunkel E.J., Boisvert J., Johnston B., Campbell J.J., Genovese M.C., Greenberg H.B., and Butcher E.C. Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential. J. Clin. Invest. 107 (2001) 595-601
21. Hase K., Murakami T., Takatsu H., Shimaoka T., Iimura M., Hamura K., Kawano K., Ohshima S., Chihara R., Itoh K., Yonehara S., and Ohno H. The membrane-bound chemokine CXCL16 expressed on follicle-associated epithelium and M cells mediates lympho-epithelial interaction in GALT. J. Immunol. 176 (2006) 43-51
22. Wagsater D., and Dimberg J. Expression of chemokine receptor CXCR6 in human colorectal adenocarcinomas. Anticancer Res. 24 (2004) 3711-3714
23. Seiderer J., Dambacher J., Leistner D., Niess J.H., Pfennig S., Diebold J., Haller D., Goeke B., Ochsenkuehn T., Lohse P., Reinecker H.C., and Brand S. Enhanced expression of the chemokine CXCL16 in intestinal inflammation and association of the CXCL16 p.Ala181Val polymorphism with early disease onset and ileal involvement in patients with Crohn's disease (abstract). Gastroenterology 132 (2007) A75
24. Kwon K.H., Ohigashi H., and Murakami A. Dextran sulfate sodium enhances interleukin-1beta release via activation of p38 MAPK and ERK1/2 pathways in murine peritoneal macrophages. Life Sci. 81 (2007) 362-371
25. Lundberg G.A., Kellin A., Samnegard A., Lundman P., Tornvall P., Dimmeler S., Zeiher A.M., Hamsten A., Hansson G.K., and Eriksson P. Severity of coronary artery stenosis is associated with a polymorphism in the CXCL16/SR-PSOX gene. J. Intern. Med. 257 (2005) 415-422
26. Lennard-Jones J.E. Classification of inflammatory bowel disease. Scand. J. Gastroenterol., Suppl. 170 (1989) 2-6 (discussion 16-19)
27. Gasche C.S.J., Schölmerich J., Brynskov J., D'Haens G., Hanauer S.B., Irvine E.J., Jewell D.P., Rachmilewitz D., Sachar D.B., Sandborn W.J., and Sutherland L.R. A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm. Bowel Dis. 6 (2000) 8-15
28. Schnitzler F., Brand S., Staudinger T., Pfennig S., Hofbauer K., Seiderer J., Tillack C., Göke B., Ochsenkühn T., and Lohse P. Eight novel CARD15 variants detected by DNA sequence analysis of the CARD15 gene in 111 patients with inflammatory bowel disease. Immunogenetics 58 (2005) 99-106
29. Seiderer J., Schnitzler F., Brand S., Staudinger T., Pfennig S., Herrmann K., Hofbauer K., Dambacher J., Tillack C., Sackmann M., Göke B., Lohse P., and Ochsenkühn T. Homozygosity for the CARD15 frameshift mutation 1007fs predicts early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis. Scand. J. Gastroenterol. 41 (2006) 1421-1432
30. Seiderer J., Brand S., Herrmann K.A., Schnitzler F., Hatz R., Crispin A., Pfennig S., Schoenberg S.O., Goke B., Lohse P., and Ochsenkuhn T. Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study. Inflamm. Bowel Dis. 12 (2006) 1114-1121
31. Rioux J.D., Xavier R.J., Taylor K.D., Silverberg M.S., Goyette P., Huett A., Green T., Kuballa P., Barmada M.M., Datta L.W., Shugart Y.Y., Griffiths A.M., Targan S.R., Ippoliti A.F., Bernard E.J., Mei L., Nicolae D.L., Regueiro M., Schumm L.P., Steinhart A.H., Rotter J.I., Duerr R.H., Cho J.H., Daly M.J., and Brant S.R. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39 (2007) 596-604
32. Prescott N.J., Fisher S.A., Franke A., Hampe J., Onnie C.M., Soars D., Bagnall R., Mirza M.M., Sanderson J., Forbes A., Mansfield J.C., Lewis C.M., Schreiber S., and Mathew C.G. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 132 (2007) 1665-1671
33. Niess J.H., Brand S., Gu X., Landsman L., Jung S., McCormick B.A., Vyas J.M., Boes M., Ploegh H.L., Fox J.G., Littman D.R., and Reinecker H.C. CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science 307 (2005) 254-258
34. Becker C., Wirtz S., Blessing M., Pirhonen J., Strand D., Bechthold O., Frick J., Galle P.R., Autenrieth I., and Neurath M.F. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J. Clin. Invest. 112 (2003) 693-706
35. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W., Kistner E.O., Schumm L.P., Lee A.T., Gregersen P.K., Barmada M.M., Rotter J.I., Nicolae D.L., and Cho J.H. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
36. Glas J., Seiderer J., Wetzke M., Konrad A., Török H.P., Schmechel S., Tonenchi L., Grassl C., Dambacher J., Pfennig S., Maier K., Griga T., Klein W., Epplen J.T., Schiemann U., Folwaczny C., Lohse P., Göke B., Ochsenkühn T., Müller-Myhsok B., Folwaczny M., Mussack T., and Brand S. rs1004819 is the main disease-associated IL23R variant in German Crohn's disease patients: combined analysis of IL23R, CARD15, and OCTN1/2 variants. PLoS One 2 (2007) e819
37. Abel S., Hundhausen C., Mentlein R., Schulte A., Berkhout T.A., Broadway N., Hartmann D., Sedlacek R., Dietrich S., Muetze B., Schuster B., Kallen K.J., Saftig P., Rose-John S., and Ludwig A. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172 (2004) 6362-6372
38. Lehrke M., Millington S.C., Lefterova M., Cumaranatunge R.G., Szapary P., Wilensky R., Rader D.J., Lazar M.A., and Reilly M.P. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J. Am. Coll. Cardiol. 49 (2007) 442-449